Gemcitabine Induces Microvesicle Particle Release in a Platelet-Activating Factor-Receptor-Dependent Manner via Modulation of the MAPK Pathway in Pancreatic Cancer Cells
Studies, including ours, have shown that pro-oxidative stressors, such as chemotherapeutic agents, generate oxidized lipids with agonistic platelet-activating factor (PAF) activity. Importantly, recent reports have implicated that these PAF-agonists are transported extracellularly via microvesicle p...
Main Authors: | Anita Thyagarajan, Sayali M. Kadam, Langni Liu, Lisa E. Kelly, Christine M. Rapp, Yanfang Chen, Ravi P. Sahu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/20/1/32 |
Similar Items
-
The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance
by: Omar Elaskalani, et al.
Published: (2017-10-01) -
Platelet-Activating Factor-Receptor Signaling Mediates Targeted Therapies-Induced Microvesicle Particles Release in Lung Cancer Cells
by: Shreepa J. Chauhan, et al.
Published: (2020-11-01) -
Platelet-Derived Microvesicles in Cardiovascular Diseases
by: Maria T. K. Zaldivia, et al.
Published: (2017-11-01) -
Ultraviolet-B radiation induces release of bioactive microvesicle particles in keratinocytes via platelet-activating factor and acid sphingomyelinase
by: Liu, Langni
Published: (2020) -
Imexon and Gemcitabine: Mechanisms of Synergy against Human Pancreatic Cancer
by: Roman, Nicholas
Published: (2005)